Insulet
PODD
#1049
Rank
$21.43 B
Marketcap
$304.49
Share price
-3.62%
Change (1 day)
13.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): $0.36 Billion USD

According to Insulet's latest financial reports the company's current earnings are $2.52 Billion USD. In 2024 the company made an earning of $0.34 Billion USD, an increase over its 2023 earnings that were of $0.25 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.36 B6.07%
2024 $0.34 B36.72%
2023 $0.25 B481.9%
2022 $43.1 M-45.24%
2021 $78.7 M43.35%
2020 $54.9 M18.51%
2019 $46.32 M41.16%
2018 $32.81 M-711.95%
2017 -$5.37 Million-56.85%
2016 -$12.43 Million-79.31%
2015 -$60.09 Million63.85%
2014 -$36.68 Million31.04%
2013 -$27.99 Million-21.96%
2012 -$35.87 Million
2010 -$34.21 Million-42.38%
2009 -$59.36 Million-33.56%
2008 -$89.35 Million65.93%
2007 -$53.85 Million209.75%
2006 -$17.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
$0.12 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-$0.21 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$0.97 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$6.40 B 1,659.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$22.50 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA